🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is Single-center, randomized, open-label, single-dose, two-period cros...
Status
Completed
Location
Chengdu Xinhua Hospital
Start Date
2026-01-04
Trial ID
NCT07300436
Treatments Being Tested
This study aimed to evaluate the pharmacokinetic characteristics and bioequ...
Status
Completed
Location
The First Affiliated Hospital of Bengbu Medical College
Start Date
2021-05-10
Trial ID
NCT05860530
Treatments Being Tested
The goal of this clinical study is to evaluate the bioavailability of two s...
Status
Completed
Location
The First Affiliated Hospital of Bengbu Medical College
Start Date
2025-08-11
Trial ID
NCT06749236
This is an open-label, randomized, single-center, single-dose, crossover, i...
Status
Completed
Location
State Autonomous Healthcare Facility of the Yaroslavl Region "Clinical Hospital No. 2"
Start Date
2019-03-23
Trial ID
NCT03898193
Treatments Being Tested
This study is open to women with overweight or obesity who are otherwise he...
Status
Completed
Location
Charité Research Organisation GmbH
Start Date
2023-12-21
Trial ID
NCT05896384
Treatments Being Tested
This is a single-center, open, randomized, single-dose, two-cycle, two-sequ...
Status
Unknown
Location
Multiple Locations
Start Date
2024-01-23
Trial ID
NCT06226506
Treatments Being Tested
This study is a randomized, open-label, single dose, 2-way crossover study ...
Status
Completed
Location
Chonbuk National University Hospital
Start Date
2015-08
Trial ID
NCT02627027
Treatments Being Tested
This is an open-labeled, randomized, two period, single-center, crossover, ...
Status
Unknown
Location
Ligand Research LLC
Start Date
2023-06-24
Trial ID
NCT05940909
Τherapeutic equivalence, randomized, multiple-dose, placebo-controlled, obs...
Status
Completed
Location
BECRO Ltd.
Start Date
2018-10-02
Trial ID
NCT03676413
In this trial, 36 healthy subjects are planned to be enrolled in postprandi...
Status
Unknown
Location
Multiple Locations
Start Date
2023-12-20
Trial ID
NCT06180720